Correction: Systematic analysis of IL-6 as a predictive biomarker and desensitizer of immunotherapy responses in patients with non-small cell lung cancer (BMC Medicine, (2022), 20, 1, (187), 10.1186/s12916-022-02356-7)

Abstract

After publication of the original article [1], it came to the authors’ attention that there is an error in the originally- published version of Additional file 1: Table S2 and Table S3. In the univariate and multivariate regression analyses of the association between baseline plasma or tumor tissue IL-6 levels and clinical factors for the prediction of progression-free survival (PFS), the results of smoking history were lost. The correct version of Additional file 1: Table S2 and Table S3 is published in this erratum.